Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Quantifying Hepatic Mitochondrial Fluxes in Humans [Phase 4]
A Phase 4 clinical trial at the University of Texas Health Science Center at San Antonio is investigating hepatic mitochondrial fluxes in ad…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Thermoacoustic Method for Estimating Liver Fat Fraction
Clinical trial investigating a thermoacoustic method to estimate liver fat fraction in MASLD/MASH and nonalcoholic fatty liver disease, curr…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH ) [Phase 2]
A Phase 2 clinical trial evaluating HP515 for non-alcoholic fatty liver disease, including potential nonalcoholic steatohepatitis, is curren…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
The trial aims to characterize the abundance and distribution of lipids and proteins in nonalcoholic fatty liver disease and is currently en…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children [NA]
This clinical trial update describes an imaging-based quantitative biomarker assay being studied for pediatric nonalcoholic fatty liver dise…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating erdosteine for nonalcoholic fatty liver disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Recruitment is ongoing for a study examining screening and follow-up in patients with HIV infection and metabolic-associated fatty liver dis…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prevalence of NAFLD in T2DM Patients [NA]
This clinical trial update notes an observational study on the prevalence of nonalcoholic fatty liver disease in patients with type 2 diabet…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
A phase 1/2 clinical trial of cilostazol for nonalcoholic fatty liver disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography
A multicenter clinical study is evaluating a visual transient elastography method to noninvasively assess hepatic steatosis and fibrosis in …
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Digoxin In NASH (CODIN) [Phase 2]
Phase 2 trial (CODIN) evaluating digoxin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Accurate Point of Care Liver Disease Diagnostics
Clinical trial update for an accurate point-of-care diagnostic targeting nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients [NA]
A clinical trial is evaluating whether adding Transcutaneous Electrical Nerve Stimulation to a Mediterranean diet affects appetite and liver…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
A clinical trial update from Assiut University is investigating whether uric acid levels relate to liver fibrosis in obese patients with hyp…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Clinical trial assessing the prevalence of nonalcoholic fatty liver disease and advanced liver fibrosis in patients with Type 1 diabetes. Th…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
A clinical trial update describing a study to evaluate a new MRI-based technology for non-invasive quantitative assessment of systemic metab…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: The Franciscus Obesity NASH Study
Clinical trial registry update for the Franciscus Obesity NASH Study, investigating NAFLD/NASH and obesity. The study status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Blood Collection Biorepository for Liver Disease Research
SUNY Buffalo is conducting a blood collection biorepository for liver disease research, currently recruiting participants to provide samples…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men [NA]
University of Arizona-sponsored clinical trial investigating gender- and culturally tailored strategies to reduce nonalcoholic fatty liver d…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD） [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of multiple subcutaneous injections of B1344 in patients with nonalcoholic fatty liv…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Fatty Liver and Pancreatic Steatosis
The clinical trial is investigating Exocrine Pancreatic Insufficiency with fatty liver disease, including nonalcoholic fatty liver disease a…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
This clinical trial update describes a study on biomarkers of steatohepatitis in patients with type 2 diabetes, which is currently not yet r…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
ClinicalTrials.gov listing for a recruiting study evaluating the effects of pectin supplementation on systemic inflammation, the gut microbi…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Prevalence of NAFLD in T1DM Patients [NA]
A recruiting observational study from Ziekenhuis Oost-Limburg aims to determine how common nonalcoholic fatty liver disease is among people …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis [NA]
This clinical trial update describes NCT02933554, evaluating bariatric embolization of arteries as a treatment for nonalcoholic steatohepati…